Mecrator Medical considers buy-back

Mercator Medical plans that the buyback of its own shares - declared in the amount of up to PLN 100 million within 12 months - will be carried out on behalf of the parent company by its subsidiary registered in the Netherlands, according to the statements of the financial director Michał Romański.

"The parent company has no formal possibility, the alternative is to make this purchase through partner companies - in this case we are thinking about our Dutch company" - said Romański during the press videoconference.

He recalled that during the January extraordinary general meeting, the shareholders authorized two of Mercator's subsidiaries to make such a share buyback.


At the same time, the management board informed about the intention to purchase Mercator Medical shares by subsidiaries, in accordance with the authorization granted in the resolution of the Extraordinary General Meeting of January 27, 2022 on the consent to the acquisition of Mercator Medical shares by subsidiaries and authorizing these subsidiaries to acquire shares in the number of not exceeding 20% ​​of the issuer's share capital. As declared by the management board, its intention is that the share buyback will be carried out within 12 months up to the amount of PLN 100 million.

The Mercator Medical Group states that it is a leader in Poland and one of the key players in Central and Eastern Europe on the market of disposable medical gloves. It owns a production plant in Thailand. The group operates globally in over 50 countries. In 2013, the company debuted on the WSE. Its consolidated sales revenues reached PLN 1.73 billion in 2021. 

Source